- Research Areas
- Immuno-Oncology
- Liquid Biopsy
- Solid Tumor
- Research Methods
- Cancer Cell Culture
- Copy Number Analysis Using Microarrays
- Digital PCR
- Gene Expression Profiling
- Flow Cytometry Immuno-Oncology
- Immuno-Oncology ELISA Kits/a>
- Methylation Analysis
- NGS Confirmation
- Organoids, Spheroids & 3D Cell Culture
- SNP Genotyping
- Sanger Sequencing
- Targeted Next-Generation Sequencing (NGS)
- Research Applications
- Cancer Genomics
- Cancer RNA Expression
- Cancer Biomarker Research
- Cancer Cell Analysis
- Screening Prior to Sequencing, Genetic Rearrangement, Mutation Detection
- Cancer Genotyping—Somatic and Germline
- SeqStudio Oncology Applications
Let nothing stand in the way of your next discovery
Fighting cancer is more than your research—it’s your passion to advance science in the pursuit of better outcomes. Every factor in the service of this struggle is precious: from samples, technology, data, and budgets, to those who depend on your success. Every day, cancer continues to devastate lives. There’s simply no room for waste or error
Because the obstacles are great and challenges many, we must partner together to become more efficient, move faster, and evolve more quickly than this tenacious disease. We at Thermo Fisher Scientific propose a bold new path forward to empower your next discovery.
Find out how collaboration is advancing immunotherapy research.
Quick links
Research areas
Immuno-oncology research
Time is precious—get results from precious samples faster with the clog-resistant Attune NxT flow cytometer
Liquid biopsy research
Techniques are vital—the most comprehensive liquid biopsy tools
Solid tumor research
Samples are precious—reassurance and enhanced sensitivity with our cell viability portfolio
Research methods & techniques
- Antibody labeling
- Cancer cell culture
- Cancer cell culture basics
- Cancer research antibodies
- Cancer transfection
- Cell isolation
- Copy number analysis using microarrays
- Digital PCR for liquid biopsies
- DNA/RNA isolation
- Exosome isolation
- Flow cytometry immuno-oncology
- Fluorescent protein labeling
- Gene expression profiling
- Genome editing
- Immuno-oncology ELISA kits
- Isolation of cancer cell DNA
- Methylation analysis
- Microsatellite instability
- NGS confirmation
- Protein purification
- Quantitative fluorescence PCR
- Sanger sequencing
- Single-strand conformation polymorphism
- SNP genotyping
- Targeted next-generation sequencing (NGS)
Research applications
- Antibody drug conjugates
- Cancer 3D spheroids
- Cancer biomarker research
- Cancer cell analysis
- Cancer genomics
- Cancer genotyping—somatic and germline
- Cancer RNA expression
- Cancer stem cells
- Epigenetics
- Low-level somatic mutation detection in tumor FFPE samples
- Low-level somatic mutation detection in tumor FFPE samples
- SeqStudio oncology applications
Watch our documentary focusing on Professor Orla Shiels and team from Trinity Translational Medical Institute in Dublin.
View our documentary spotlighting Dr. Paul Boutros and team from The Ontario Institute of Cancer Research.
Publications
Watch our documentary focusing on Professor Orla Shiels and team from Trinity Translational Medical Institute in Dublin.
View our documentary spotlighting Dr. Paul Boutros and team from The Ontario Institute of Cancer Research.
Our commitment to you in this partnership
We will help shorten your path to breakthrough by enabling you to maximize every resource: time, technology, money, data, and the brilliance of your work
We’ll be with you at every step, providing unfettered access to the tools, innovations, and support you require to make crucial discoveries
We have consolidated here in one place all of the technologies and resources we offer to help you at every stage of your research journey—and will continue to maintain and update this vital source
Together we can be smarter, more efficient, faster, and more determined than ever. The extraordinary talents and technologies of this generation promise to transform the future of cancer research and treatment. Let a new era of collaboration in the fight against cancer begin here and now.